Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Male Infertility Market?

The market size for male infertility has seen solid growth in the past few years. The market is projected to expand from $3.59 billion in 2024 to $3.79 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.6%. Factors contributing to the growth during the historic period include increased awareness about men’s reproductive health, growing instances of lifestyle-related diseases, rising adoption of assisted reproductive technologies (ART), proliferation of fertility clinics and diagnostic centres, and progress in semen analysis technologies.

What Growth Rate Is Forecasted for the Male Infertility Market by 2029?

A robust expansion is anticipated in the male infertility market in the coming years, with an expected valuation of $4.66 billion by 2029. The market’s compound annual growth rate (CAGR) is projected to be 5.3%. This predicted expansion during the forecast period could be credited to a heightening focus on genetic and epigenetic aspects, an escalation in the demand for custom-made infertility treatments, development in the realm of fertility care medical tourism, advancements in sperm retrieval and storage technology, and the burgeoning incorporation of telehealth into fertility consultations. Key trends during the forecast period encompass an increasing implementation of genetic testing for diagnosing infertility, innovations in sperm retrieval procedures like micro-TESE, elevated demand for non-intrusive fertility treatments, the launch of tailored treatment plans for male infertility, and the upsurge in the utilization of stem cell therapy to restore spermatogenesis.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24286&type=smp

Which Key Companies Are Shaping the Future of the Male Infertility Market?

Major companies operating in the male infertility market are Novartis AG, Amgen Inc., Teva Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., NYU Langone Hospitals, Sun Pharmaceutical Industries Ltd., Cipla Limited, Ferring Pharmaceuticals, Fortis Healthcare, Vitrolife, Max Healthcare, CinnaGen Co., Aytu BioScience Inc., Zydus Hospitals and Healthcare Research Private Limited, Apricus Biosciences Inc., SCSA Diagnostics Inc., Andrology Solutions, Halotech DNA, Indira IVF, Conduit Pharmaceuticals, Shree IVF Clinics

Which Factors Are Driving Demand in the Male Infertility Industry?

The male infertility market is anticipated to grow due to the escalating stress levels. Stress levels pertain to the severity of emotional, physical, or mental distress experienced when facing difficult situations or burdens. The surge in stress levels arises from mounting workloads, whereby relentless stress and high expectations contribute to burnout, disrupting mental health and the equilibrium between work and life. Heightened stress can disturb hormone balance, negatively affect sperm quality, and hinder sexual performance, resulting in male infertility. Persistent stress can alter cortisol and testosterone amounts, leading to an uptick in infertility incidents. For example, in May 2024, as per the American Psychiatric Association, a US-based association of psychology professionals, 43% of American adults reported feeling more anxious in 2024, compared to 37% in 2023 and 32% in 2022, illustrating a steady rise in anxiety rates. Thus, the rising stress levels are propelling the expansion of the male infertility market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24286&type=smp

How Is the Male Infertility Market Segmented by Several Divisions?

The male infertility market covered in this report is segmented –

1) By Treatment Type: Medication, Surgery, Assisted Reproductive Technology

2) By Test Type: Sperm Agglutination, Deoxyribonucleic Acid Fragmentation Technique, Oxidative Stress Analysis, Computer Assisted Semen Analysis, Sperm Penetration Assay, Other Test Types

3) By Distribution Channel: Hospitals Pharmacies, Pharmacies And Drug Stores, Online Pharmacies

4) By End-User: Hospitals And Clinics, Fertility Centers, Research Institutes, Other End-Users

Subsegments:

1) By Medication: Hormone Treatments, Gonadotropins, Antibiotics, Antiestrogens, Dopamine Agonists

2) By Surgery: Varicocelectomy, Vasovasostomy, Epididymovasostomy, Transurethral Resection of the Ejaculatory Duct (TURED), Sperm Retrieval Procedures

3) By Assisted Reproductive Technology (ART): In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), Sperm Donation, Cryopreservation Of Sperm

What are the Emerging Market Trends Driving the Growth of the Male Infertility Industry?

Leading businesses in the male infertility market are adopting strategies for partnerships with the aim of enhancing accessibility to superior fertility treatments worldwide. These strategic partnerships, essentially collaborations that merge the resources and expertise of different organizations, have the capacity to foster innovation, extend the market reach, and strengthen research and development activities. For example, in June 2024, Switzerland’s Ferring Pharmaceuticals formed a partnership with Posterity Health, an American male fertility clinic. Their collaboration resulted in the launch of a male fertility program on Ferring’s Fertility Out Loud platform, a major educational resource to enlighten men on fertility issues. This initiative provides a private online appraisal and educational materials curated by reproductive urologists to help men understand their fertility state and decrease the stigma associated with male infertility – a problem accounting for about 50% of infertility instances. The ultimate goal of the program is to inspire men to take prompt actions that could enhance the journey towards parenthood for couples by addressing male fertility complications earlier and in a more accessible way via digital tools and telehealth services.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/male-infertility-global-market-report

Which Regions Are Driving Growth in the Male Infertility Market?

North America was the largest region in the male infertility market in 2024. The regions covered in the male infertility market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/customise?id=24286&type=smp

This Report Delivers Insight On:

1. How big is the male infertility market, and how is it changing globally?

2. Who are the major companies in the male infertility market, and how are they performing?

3. What are the key opportunities and risks in the male infertility market right now?

4. Which products or customer segments are growing the most in the male infertility market?

5. What factors are helping or slowing down the growth of the male infertility market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model